6 курс / Кардиология / Белялов Ф. И. - Аритмии сердца - 2014

651.Swiryn S. RATE registry: Longer bouts of atrial arrhythmia have worse outcomes. American Heart Association 2012 Scientific Sessions. http://www.theheart.org/article/1475603.do.

652.Sy R.W., van der Werf C., Chattha I.S. et al. Derivation and Validation of a Simple Exercise-Based Algorithm for Prediction of Genetic Testing in Relatives of LQTS Probands. Circulation. 2011;124(20):2187–94.

653.Schwartz P.J., Moss A.J., Vincent G.M., Crampton R.S. Diagnostic criteria for the long QT syndrome. An update. Circulation. 1993;88:782–4.

654.Taggart N.W., Haglund C.M., Tester D.J. et al. Diagnostic miscues in congenital long–QT syndrome. Circulation. 2007;115:2613–20.

655.Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J. 2001;22:1374–450.

656.Turakhia MP, Santangeli P, Winkelmayer WC, et al. Increased Mortality Associated With Digoxin in Contemporary Patients With Atrial Fibrillation: Findings From the TREAT-AF Study. J Am Coll Cardiol. 2014;64(7):660–8.

657.Teo K.K., Yusuf S., Furberg C.D. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA. 1993;270:1589–95.

658.Terasawa T., Balk E.M., Chung M. et al. Systematic Review: Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation. Ann Intern Med. 2009;151(3):191–202.

659.Tischer T.S., Hollstein A., Voss W. et al. A historical perspective of pacemaker infections: 40-years single-centre experience. Europace. 2014;16(2):235-40.

660.Toff W.D., Camm A.J., Skehan J.D., the United Kingdom Pacing and Cardiovascular Events (UKPACE) Trial Investigators. Single–Chamber versus Dual-Chamber Pacing for High–Grade Atrioventricular Block. N Engl J Med. 2005;353(2):145–55.

661.Trivalle C., Doucet J., Chassagne P. et al. Differences in the signs and symptoms of hyperthyroidism in older and younger patients. J Am Geriatr Soc. 1996;44 (1):50–3.

662.Tsadok M.A., Jackevicius C.A., Essebag V. et al. Rhythm Versus Rate Control Therapy and Subsequent Stroke or Transient Ischemic Attack in Patients With Atrial Fibrillation. Circulation. 2012;126(23):2680–7.

663.Tzivoni D., Keren A. Supression of ventricular arrhythmias by magnesium. Am J Card. 1990;65:1397–9.

664.Update of guidelines on sudden cardiac death of European Society of Cardiology. Eur Heart J. 2003;24:13–5.

665.Ulimoen S.R., Enger S., Carlson J. et al. Comparison of Four Single-Drug Regimens on Ventricular Rate and Arrhythmia-Related Symptoms in Patients With Permanent Atrial Fibrillation. The American journal of cardiology. 2013;111[2]:225–30.

666.Upadhyay G.A., Choudhry N.K., Auricchio A. et al. Cardiac Resynchronization in Patients With Atrial Fibrillation: A Meta-Analysis of Prospective Cohort Studies. J Am Coll Cardiol. 2008;52:1239–46.

667.Van Brabandt H., Neyt M., Devos C. Effectiveness of catheter ablation of atrial fibrillation in Belgian practice: a cohort analysis on administrative data. Europace. 2013;15 (5):663–8.

668.Van Gelder I.C., Crijns H.J., Tieleman R.G. et al. Chronic atrial fibrillation: success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med. 1996;156:2585–92.

669.Van Gelder I.C., Groenveld H.F., Crijns H.J.G.M. et al. Lenient versus Strict Rate Control in Patients with Atrial Fibrillation. N Engl J Med. 2010;362(15):1363–73.

670.Van Gelder I.C., Haegeli L.M., Brandes A. et al. Rationale and current perspective for early rhythm control therapy in atrial fibrillation. Europace. 2011;13(11):1517–25.

671.Van Noord T., Van Gelder I.C., Crijns H.J. How to enhance acute outcome of electrical cardioversion by drug therapy: importance of immediate reinitiation of atrial fibrillation. J Cardiovasc Electrophysiol. 2002;13(8):822–5.

351

672.Van Rees J.B., de Bie M.K., Thijssen J. et al. Implantation-Related Complications of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy Devices: A Systematic Review of Randomized Clinical Trials. J Am Coll Cardiol. 2011;58(10):995–1000.

673.Van Rees J.B., Willem Borleffs C.J., Thijssen J. et al. Prophylactic implantable car- dioverter-defibrillator treatment in the elderly: therapy, adverse events, survival gain. Europace. 2012;14(1):66–73.

674.Vazquez S.R., Johnson S.A., Rondina M.T. Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation. Thromb Res. 2010;126(2):e69–77.

675.Vega F., Mehta M., Young M.-L. Successful Radiofrequency Catheter Ablation of a Chaotic Atrial Tachycardia. HeartWeb. 1999;4(9).

676.Verma A., Champagne J., Sapp J. et al. Discerning the Incidence of Symptomatic and Asymptomatic Episodes of Atrial Fibrillation Before and After Catheter Ablation (DISCERN AF): A Prospective, Multicenter Study. JAMA Intern Med. 2013;173(2):149– 56.

677.Vidal E., Tom H., Robert W.P. et al. Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction. J Am Coll Cardiol. 2003;41:249–54.

678.Viles-Gonzalez J.F., Kar S., Douglas P. et al. The Clinical Impact of Incomplete Left Atrial Appendage Closure With the Watchman Device in Patients With Atrial Fibrillation: A PROTECT AF Substudy. J Am Coll Cardiol. 2012;59(10):923–9.

679.Viskin S. The QT interval: too long, too short or just right. Heart Rhythm. 2009;6(5):711–5.

680.Volgman A.S., Carberry P.A., Stambler B. et al. Conversion Efficacy and Safety of Intravenous Ibutilide Compared With Intravenous Procainamide in Patients With Atrial Flutter or Fibrillation. J Am Coll Cardiol. 1998;31:1414–9.

681.Volpi A., Cavalli A., Turato R. et al. Incidence and short–term prognosis of late sustained ventricular tachycardia after myocardial infarction: results of the GISSI-3 Data Base. Am Heart J. 2001;142:87–92.

682.Vrtovec B., Knezevic I., Poglajen G. et al. Relation of B-Type Natriuretic Peptide Level in Heart Failure to Sudden Cardiac Death in Patients With and Without QT Interval Prolongation. The American journal of cardiology. 2013;111[6]:886-90.

683.Waldo A.L., Prystowsky E.N. Drug Treatment of Atrial Fibrillation in the Managed Care Era. Am J Card. 1998;81:23C–9C.

684.Wallentin L., Yusuf S., Ezekowitz M.D. et al. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation. The Lancet. 2010;376:975–83.

685.Wang Y.L., Liu X.U., Tan H.W. et al. Evaluation of Linear Lesions in the Left and Right Atrium in Ablation of Long-standing Atrial Fibrillation. Pacing and Clinical Electrophysiology. 2013;36(10):1202–10.

686.Wazni O.M., Marrouche N.F., Martin D.O. et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. 2005;293:2634–40.

687.Weber B.E., Kapoor W.N. Evaluation and outcomes of patients with palpitations. Am J Med. 1996;100:138–48.

688.Weerasooriya R., Davis M., Powell A. et al. The Australian intervention randomized control of rate in atrial fibrillation trial (AIRCRAFT). J Am Coll Cardiol. 2003;41:1697– 702.

689.Wellens H.J.J., Brugada P., Heddle W.F. The value of the 12-lead ECG in diagnosing and mechanism of a tachycardia: a servey among 22 cardiologists. J Am Coll Cardiol. 1984;4:176–9.

690.Wellens H.J., Chu-Pak Lau, Luderitz B. et al. Atrioverter: An Implantable Device for the Treatment of Atrial Fibrillation. Circulation. 1998;98:1651–6.

691.Wellens H.J. Pulmonary vein ablation in atrial fibrillation: hype or hope? Circulation. 2000;102:2562–4.

352

692.Welles C.C., Whooley M.A., Na B. et al. The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: Data from the Heart and Soul Study. Am Heart J. 2011;162[3]:555–61.

693.Weerasooriya R., Khairy P., Litalien J. et al. Catheter Ablation for Atrial Fibrillation: Are Results Maintained at 5 Years of Follow-up? J Am Coll Cardiol. 2011;57(2):160– 6.

694.Whitbeck M.G., Charnigo R.J., Khairy P. et al. Increased mortality among patients taking digoxin-analysis from the AFFIRM study. Eur Heart J 2013;34(20):1481–8.

695.Widerhorn J., Widerhorn A.L.M., Rahimtoola S.H., Elkayam U. WPW syndrome during pregnancy: Increased incidence of supraventricular arrhythmias. Am Heart J. 1992;124:796.

696.Wiesel J., Fitzig L., Herschman Y., Messineo F.C. Detection of atrial fibrillation using a modified microlife blood pressure monitor. Am J Hypertens. 2009;22(8):848–52.

697.Wijnmaalen A.P., Schalij M.J., von der Thusen J.H. et al. Early Reperfusion During Acute Myocardial Infarction Affects Ventricular Tachycardia Characteristics and the Chronic Electroanatomic and Histological Substrate. Circulation 2010;121(17):1887– 95.

698.Wilber D.J., Pappone C., Neuzil P. et al. Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation: A Randomized Controlled Trial. JAMA. 2010;303(4):333–40.

699.Wilton S.B., Leung A.A., Ghali W.A. et al. Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm. 2011;8:1088–94.

700.Winkle R.A., Mead R.H., Engel G. et al. Relation of Early Termination of Persistent Atrial Fibrillation by Cardioversion or Drugs to Ablation Outcomes. Am J Cardiol. 2011;108[3]:374–9.

701.Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983–8.

702.Wolk R., Kulakowski P., Karczmarewicz S. et al. The incidence of asymptomatic paroxysmal atrial fibrillation in patients treated with propranolol or propafenone. Int J Cardiol. 1996, 54:207–11.

703.Wong K.K., Mirza I.H., Nathwani V., Bashir Y. Exercise-Induced Polymorphic, Broad Complex Tachycardia?. J Am Coll Cardiol. 2013;61(17):1830.

704.Wong J.M., Welles C.C., Azarbal F. et al. Relation of Left Atrial Dysfunction to Ischemic Stroke in Patients With Coronary Heart Disease (from the Heart and Soul Study). The American journal of cardiology. 2014;113:1679–84.

705.Wood M.A., Curtis A.B., Takle-Newhouse T.A. et al. Survival of DDD Pacing Mode After Atrioventricular Junction Ablation and Pacing for Refractory Atrial Fibrillation. Am Heart J. 1999;137(4):682–5.

706.Wren C., Campbell R.W., Hunter S. Role of echocardiography in differential diagnosis of broad complex tachycardia. Br Heart J. 1985;54(2):166–72.

707.Wu S., Lin X., Cheng Y., Qiang C., Zhang J. Early Repolarization Pattern and Risk for Arrhythmia Death: A Meta-Analysis. J Am Coll Cardiol. 2013;61(6):645–50.

708.Wyse D.G., Friedman P.L., Brodsky M.A. et al. Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up. J Am Coll Cardiol. 2001;38:1718–24.

709.Yamabe H., Shimasaki Y., Honda O. et al. Demonstration of the Exact Anatomic Tachycardia Circuit in the Fast-Slow Form of Atrioventricular Nodal Reentrant Tachycardia. Circulation. 2001;104:1268.

710.Yang F., Hanon S., Lam P., Schweitzer P. Quinidine revisited. Am J Med. 2009;122(4):317–21.

711.Yankelson L., Sadeh B., Gershovitz L. et al. Life-Threatening Events During Endurance Sports: Is Heat Stroke More Prevalent Than Arrhythmic Death?. J Am Coll Cardiol. 2014;64(5):463–9.

353

712.Yokokawa M., Mueller G., Bogun F. Role of imaging in ablation therapy of ventricular arrhythmias. Focus on cardiac magnetic resonance imaging. Circ J. 2012;76(6):1292– 8.

713.Yokokawa M., Kim H.M., Good E. et al. Relation of symptoms and symptom duration to premature ventricular complex-induced cardiomyopathy. Heart Rhythm. 2012;9(1):92–5.

714.Yokokawa M., Good E., Crawford T. et al. Recovery from left ventricular dysfunction after ablation of frequent premature ventricular complexes. Heart rhythm. 2013;10[2]:172–5.

715.Yu C.M., Chan J.Y.-S., Zhang Q. et al. Biventricular Pacing in Patients with Bradycardia and Normal Ejection Fraction. N Engl J Med. 2009;361(22):2123–34.

716.Zado E., Callans D.J., Riley M. et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly. J Cardiovasc Electrophysiol. 2008;19:621– 6.

717.Zaidi A., Sharma S. Exercise and heart disease: from athletes and arrhythmias to hypertrophic cardiomyopathy and congenital heart disease. Future Cardiol. 2013;9(1):119–36.

718.Zardini M., Yee R., Thakur R.K. et al. Risk of sudden arrhythmic death in the Wolff- Parkinson-White syndrome: Current perspectives. PACE. 1994;17:966.

719.Zareba W., Moss A.J., Schwartz P.J. et al. Influence of genotype on the clinical course of the long–QT syndrome: International Long-QT Syndrome Registry Research Group. N Engl J Med. 1998;339:960–65.

720.Zhang Y.Y., Qiu C., Davis P.J. et al. Predictors of Progression of Recently Diagnosed Atrial Fibrillation in REgistry on Cardiac Rhythm DisORDers Assessing the Control of Atrial Fibrillation (RecordAF)-United States Cohort. Am J Card. 2013;112:79–84.

721.Zhang X.-D., Gu J., Jiang W.-F. et al. Optimal rhythm-control strategy for recurrent atrial tachycardia after catheter ablation of persistent atrial fibrillation: a randomized clinical trial. European Heart Journal 2014;35:1327–34.

722.Zheng Z.J., Croft J.B., Giles W.H., Mensah G.A. Sudden Cardiac Death in the United States, 1989 to 1998. Circulation. 2001;104:2158.

723.Ziegler P.D., Glotzer T.V., Daoud E.G. et al. Detection of Previously Undiagnosed Atrial Fibrillation in Patients With Stroke Risk Factors and Usefulness of Continuous Monitoring in Primary Stroke Prevention. Am J Card. 2012;110[9]:1309–13.

354